Epidemiological studies suggest that elevated circulating ferritin is associated with heightened incident diabetes in mainly Western populations, although the results were not entirely consistent. We aimed to prospectively investigate the ferritindiabetes association in an Asian population for the first time, to our knowledge, and also to examine this association with an updated meta-analysis. Our prospective study included 2198 community-living Chinese between 50 and 70 y of age in 2005. All individuals participated in a 6-y follow-up survey in 2011. Fasting plasma ferritin, high-sensitivity C-reactive protein (hsCRP), adiponectin, and g-glutamyltransferase (GGT) were measured at baseline. A total of 538 incident diabetes cases were documented by self-reports and/or fasting glucose $7.0 mmol/L at the follow-up survey. After multiple adjustments, the RR of type 2 diabetes was 1.90 (95% CI: 1.37, 2.65) when comparing the highest with the lowest sexspecific ferritin quintile. The association remained significant after further controlling for BMI, hsCRP, adiponectin, and GGT. To update the evidence reported in previous meta-analyses, we searched all prospective studies evaluating the association between blood ferritin and incident diabetes on PubMed prior to October 24, 2012. Besides our prospective study, 9 additional studies were also included. The pooled RR was 1.60 (95% CI: 1.25, 2.04) when comparing the highest with the lowest category of ferritin with a moderate heterogeneity (I 2 = 49.0%; P = 0.03). A significant linear dose-response relationship was detected in this meta-analysis. Overall, our results indicate an independent and significant positive association between higher plasma ferritin, a marker of elevated body iron stores, and increased risk of developing type 2 diabetes in middle-aged and elderly Chinese adults, which is similar to Western populations. J. Nutr.
Introduction
Type 2 diabetes has become a global epidemic. China now has the largest diabetic population in the world with an almost 10-fold increase in prevalence within 28 y (1,2). A major driving force behind this epidemic is ChinaÕs rapid shift from a plantbased traditional diet toward a diabetogenic dietary environment combined with unhealthy lifestyles (3) . In addition, Asian populations are known to be more susceptible to metabolic diseases characterized by onset of diabetes with relatively low adipose and at younger ages (4) .
Excessive iron load can generate hydroxyl radicals via Fenton reactions (5) and the induced oxidative stress may impair insulin secretion and sensitivity (6, 7) . According to several recent prospective cohort studies in Caucasians, even moderately raised concentrations of ferritin, a marker of elevated body iron stores, were associated with a higher risk of development of type 2 diabetes (8) (9) (10) (11) . However, to our knowledge, no study has ever prospectively evaluated this association in Asian populations and thus far only one 5-y follow-up study has investigated the relationship between ferritin and hyperglycemia in Chinese adults (12) . Interestingly, despite a lower prevalence of HFE gene mutations (13) , Asian people generally have higher ferritin concentrations than Western populations. Moreover, they also tended to display a ''metabolically obese'' phenomenon (14) and different inflammatory profiles compared with Westerners (15) . Thus, the ferritin-diabetes association and its potential confounders or modifying factors need to be elucidated in Asian populations.
The findings from existing studies in Western populations were not entirely consistent. Two longitudinal studies showed null results (16, 17) , whereas one study detected the ferritin-diabetes association only in men and not in women (18) . Previously, 2 meta-analyses summarized 6 and 5 Western prospective studies, respectively (19, 20) ; however, neither evaluated the threshold effect of ferritin via dose-response meta-analysis.
Therefore, in a 6-y follow-up study of middle-aged and elderly Chinese, we aimed to investigate the association between ferritin concentrations and incidence of type 2 diabetes as well as to evaluate whether the association was independent of obesity status, inflammatory marker, adipokine, and hepatic enzyme. Additionally, we conducted an updated meta-analysis to summarize the existing evidence from prospective studies together with our cohort data. The meta-analysis also examined the dose-response relationship between ferritin concentration and diabetes risk.
Materials and Methods
Study population. The Nutrition and Health of Aging Population in China study is a population-based prospective cohort study of communityliving adults aged 50-70 y in Beijing and Shanghai (15) . It was designed to investigate the impacts of environmental and genetic factors on metabolic diseases. The study protocol was approved by the Institutional Review Board of the Institute for Nutritional Sciences and all participants provided written informed consent forms.
The baseline survey was conducted in 2005 with a total of 3289 residents (1641 from Beijing and 1648 from Shanghai) (15) . Data on demographic variables, health status and behavior, and lifestyle behaviors (smoking status, alcohol intake, and physical activity level) were obtained by a standardized questionnaire. Body weight, height, waist circumference, and blood pressure were measured in a physical examination using standardized procedures (15) . BMI was calculated as weight in kilograms divided by height in meters squared.
In 2011, all 3289 participants recruited at baseline were contacted for the 6-y follow-up visit and detailed information was previously described (21) . A total of 760 (23.1%) participants were lost to follow-up, because they were unable to be contacted (n = 554) or refused to participate (n = 206). Due to existing diabetes at baseline, 331 of 2529 eligible persons were excluded, leaving 2198 participants in the current analysis.
Laboratory measurements. At baseline, fasting peripheral venous blood samples were collected and stored at 280°C. Plasma ferritin was measured using a commercially available, particle-enhanced immunoturbidimetric kit (Shanghai Gensource). The intra-assay CVs were 0.8, 1.9, and 2.0% at 80, 123, and 199 mg/L, respectively, whereas the interassay CVs were 6.1 and 5.2% at 68 and 83 mg/L, respectively. Plasma g-glutamyltransferase (GGT) was measured by commercial reagents (Wako Pure Chemical Industries) on an automatic analyzer (Hitachi 7080). The measurements of plasma glucose, total cholesterol, HDL cholesterol, LDL cholesterol, TGs, insulin, high-sensitivity C-reactive protein (hsCRP), and adiponectin and erythrocyte glycohemoglobin were previously described (15, (22) (23) (24) . HOMA-IR was calculated as insulin (mU/mL) 3 glucose (mmol/L)/22.5. All samples were consecutively analyzed in a random fashion without knowing disease status.
Diabetes assessment. Incident diabetes cases were defined as: 1) the participants reported doctor-diagnosed diabetes or taking antidiabetic medications; and/or 2) fasting glucose $7.0 mmol/L at the follow-up visit. Studies were excluded if they were: 1) case reports, case-series, reviews, editorials, comments, or animal or in vitro studies; 2) not relevant (not using ferritin as the exposure or diabetes as the outcome); 3) not prospective studies; and 4) had no retrievable data. Titles and abstracts of identified studies were screened and potentially relevant articles were selected for full-text review (Supplemental Fig. 1 ). If data of interest were not directly presented in the publications, we contacted corresponding authors and 2 authors responded (12, 26) . Information from one of the studies was adapted from a previous meta-analysis (19, 27) . Extracted information included study characteristics (citation, study name, authors, publication year), participant characteristics (location, number, mean age or age range, gender composition, study design, follow-up years), ferritin assay, diabetes assessment, analysis strategy (statistical models and covariates), and multivariable-adjusted risk estimates. The Newcastle-Ottawa Quality Assessment Scale was applied to assess study qualities included in our meta-analysis (28) . The study selection, data extraction, and quality assessment were independently conducted by 2 authors (L.S. and G.Z.) and disagreements were resolved by consensus.
Meta
Statistical analysis. Covariate distributions across baseline sex-specific ferritin quintiles were compared using logistic regression models for categorical variables and ANCOVA for continuous variables. Logtransformations were performed for ferritin, TGs, insulin, HOMA-IR, hsCRP, adiponectin, and GGT to approximate normality. Because most of type 2 diabetes cases were diagnosed at the follow-up visit, we were unable to estimate person-year accurately. Instead, RR was calculated in a logistic regression model adjusted for baseline variables, including age (continuous), sex, region (north, south), residence (urban, rural), education attendance (0-6, 7-9, and $10 y), smoking status (current, past, never), alcohol use (yes, no), physical activity (active, inactive), and a family history of diabetes (yes, no). Baseline obesity status and other diabetes biomarkers were further adjusted to test the independence of the association including: BMI (model 2), plasma concentrations of hsCRP and adiponectin (model 3), and GGT (model 4) (all in continuous variables). Due to the high cumulative incidence of type 2 diabetes in our study (24.5%, 538/2198), in a sensitivity analysis, CIs and P-trend for type 2 diabetes were estimated using log-Poisson models, which provided consistent but not fully efficient estimates of the RRs and CIs (29) . Analyses were also stratified by age, BMI, alcohol use, physical activity, hsCRP, adiponectin, and GGT. There were 59 and 10 missing values for adiponectin and GGT, respectively. Tests for interaction were performed using likelihood ratio tests.
For the meta-analysis, RRs comparing extreme ferritin categories in each study were pooled by the DerSimonian-Laird random-effects model (30) and the results of a sensitivity analysis were based on the fixed-effects model. Heterogeneity was evaluated by the I 2 Statistic (31). The influences of study design (nested case-control, case-cohort, and cohort study), ethnicity (Western, Asian), follow-up duration (y), ferritin assessment, and study quality (continuous) on observed associations were evaluated by meta-regression (32) . Potential publication bias was examined by Egger test (33) . A sensitivity analysis was used to test the influence of individual study on the results. To detect any nonlinear relationship, the dose-response association was first evaluated by a restricted cubic spline regression model with 3 knots at the 10th (20 mg/L), 50th (89 mg/L), and 90th (204 mg/L) percentiles (34) . When the nonlinear hypothesis was rejected, a 2-stage, log-linear, dose-response regression function was then used for both fixed-effects model and random-effects model to estimate the change of diabetes incidence per 100 mg/L increase in ferritin (35) . Seven of the 10 studies (including the current study) provided the necessary data for the doseresponse meta-analysis (9, 10, 12, 16, 18, 26) . All analyses were performed with Stata version 9.2 (Stata). Two-sided P # 0.05 was considered significant.
Results
Baseline characteristics. The baseline characteristics across sex-specific ferritin quintiles are shown in Table 1 . Overall, Beijing residents and participants from urban areas had higher ferritin concentrations than their counterparts from Shanghai or rural areas. Individuals with high ferritin concentrations tended to be older. With respect to metabolic parameters, ferritin was positively associated with BMI, waist circumference, total cholesterol, LDL cholesterol, TGs, glucose, insulin, HOMA-IR, glycohemoglobin, hemoglobin, hsCRP, and GGT (all P # 0.05), and inversely related to HDL cholesterol and adiponectin concentrations (both P # 0.05).
Association of ferritin and incidence of type 2 diabetes. At the end of the 6-y follow-up, 538 (24.5%) incident diabetes cases of the 2198 participants were documented. The RRs for type 2 diabetes substantially increased across sex-specific ferritin quintiles ( Table 2) . Compared with those in the lowest quintile, individuals in the highest quintile had an RR of 1.90 (95% CI: 1.37, 2.65) after adjusting for age, sex, region, residence, lifestyle factors, and family history of diabetes (Model 1). This association was slightly attenuated but still significant when BMI was included as a covariate (Model 2). Additional adjustment for plasma hsCRP and adiponectin did not alter the association (Model 3). The magnitude of association was not affected by further controlling for GGT, which was positively correlated with ferritin (r = 0.27; P < 0.001) (Model 4). In log-Poisson models, the results were not materially changed [RR = 1.43 (95% CI: 1.10, 1.86 comparing extreme quintiles); P-trend = 0.002 in Model 4] . Excluding individuals with exceptionally high ferritin concentrations (ferritin >500 mg/L, n = 27, 1.2% of 2198 persons) had little impact on the association [RR = 1.63 (95% CI: 1.15, 2.32 comparing extreme quintiles); P-trend = 0.002] (logistic regression model). 1 Values are arithmetic means 6 SDs or geometric means (95% CIs). GGT, g-glutamyltransferase; hsCRP, high-sensitivity C-reactive protein; Q, quintile.
2 P values were adjusted for age, sex, region (Beijing/Shanghai), and residence (urban/rural). 3 P value was adjusted for sex, region (Beijing/Shanghai), and residence (urban/rural). 4 P value was adjusted for age, region (Beijing/Shanghai), and residence (urban/rural). 5 P value was adjusted for age, sex, and residence (urban/rural). 6 P value was adjusted for age, sex, and region (Beijing/Shanghai).
In the stratified analysis, the ferritin-diabetes association was slightly stronger in younger (age #60 y), overweight/obese individuals, and nondrinkers as well as in those with a lower level of physical activity and lower adiponectin concentration and higher concentrations of hsCRP and GGT compared with their counterparts (Table 3) . However, no significant interaction was observed (all P-interaction > 0.10).
Meta-analysis.
Characteristics of the other 9 retrieved prospective studies investigating the association between blood ferritin and incident diabetes are shown in Supplemental Table  1 . In total, there were 3535 diabetes cases among 21,822 participants (including the current study). The follow-up duration varied from 2.8 to 10 y and the mean ages at baseline ranged from 47.0 to 62.2 y. Most of the studies, except Jiang et al. (9) , included both men and women, whereas the study of Le et al. (18) provided risk estimates for men and women separately. Supplemental Table 2 shows quality assessment scores by NewcastleOttawa system. All included studies scored $6 points in the 9-point system. Supplemental Table 3 provids data for the doseresponse meta-analysis from 7 available studies.
The pooled RR for diabetes when comparing extreme ferritin categories was 1.60 (95% CI: 1.25, 2.04) using the randomeffects model (Fig. 1 ) and results were similar using the fixedeffects model [pooled RR = 1.61 (95% CI: 1.37, 1.89)]. Although a moderate heterogeneity (I 2 = 49.0%; P = 0.03) was observed, the meta-regression analysis did not identify any significant modification by study design, ethnicity, follow-up duration, ferritin assessment, or study quality (all P > 0.10). The strengths of the ferritin-diabetes association were comparable in Western and Asian populations (RR 1.61 vs. 1.57) in the separated analysis for these 2 ethnical populations. No 1 RRs were estimated after adjustment for age, sex, region, residence, education, smoking status, alcohol use, physical activity, family history of diabetes, BMI, and plasma hsCRP, adiponectin and GGT, except stratifying factors. There were 59 and 10 missing values for adiponectin and GGT, respectively. GGT, g-glutamyltransferase; hsCRP, highsensitivity C-reactive protein; Q, quintile; Ref, reference. 2 Physical activity data were collected by the International Physical Activity Questionnaire (short last 7-d format) (15) and the level for each individual was calculated as a sum of metabolic equivalent-minute/week score and then classified as low and high by sex-specific median.
significant publication bias was detected (P = 0.92 in the EggerÕs test). In sensitive analyses by omitting one study at one time, the pooled RRs ranged from 1.49 (95% CI: 1.17, 1.88) to 1.74 (95% CI: 1.43, 2.13). A linear dose-response relationship was suggested in the cubic spline regression model ( Fig. 2 , P = 0.24 for nonlinearity). The RRs of diabetes were 1.24 (95% CI: 1.15, 1.34; P-trend < 0.001, P-heterogeneity = 0.046) per 100 mg/L increase in ferritin in the fixed-effects log-linear model and 1.30 (95% CI: 1.14, 1.49; P-trend < 0.001) in the random-effects model.
Discussion
In a cohort study of middle-aged and elderly Chinese, we found a positive association between elevated plasma ferritin concentrations and incident diabetes after multiple adjustments, including demographic variables, lifestyle factors, family history of diabetes, obesity, hsCRP, adiponectin, and GGT. In an updated meta-analysis performed by pooling data from our cohort and 9 additional prospective studies, ferritin was associated with a 60% [RR = 1.60 (95% CI: 1.25, 2.04)] increased risk of developing diabetes by comparing extreme categories and the association appeared to be linear. Since the first publication in 1998, the association between elevated body iron stores and incident diabetes has been reported by some (8) (9) (10) (11) , but not other, Western prospective studies (16, 17) . To date, it remains unclear whether a similar association exists in Asian populations with higher circulating ferritin concentrations. In the present study, we not only observed a positive association between plasma ferritin and incident diabetes in an Asian population but also examined the association by conducting an updated meta-analysis with a large sample size (3535 cases and 18,287 non-cases) from both Western and Asian populations. The pooled RR provided strong evidence for the adverse role of elevated body iron stores in the pathogenesis of diabetes across different ethnic populations. Moreover, a significant linear dose-response relationship between ferritin concentrations and incident diabetes was observed in the meta-analysis, suggesting no threshold effect within the broad range of ferritin concentrations.
Inflammation was shown to regulate ferritin synthesis and secretion (36) and has been suggested as a major confounding factor (9) (10) (11) . However, the positive ferritin-diabetes association observed in our cohort study was not substantially attenuated by controlling for hsCRP or adiponectin (antiinflammatory adipokine). In our meta-analysis, 7 of 10 prospective studies adjusted for inflammatory markers in their final models (9) (10) (11) 16, 17, 26) and the pooled RR was 1.75 (95% CI: 1.25, 2.45). Therefore, elevated ferritin concentration might contribute to the increased type 2 diabetes risk via pathways that may not greatly overlap with chronic inflammation. Moreover, previous studies suggested that nonalcoholic fatty liver disease and/or elevated hepatic enzymes could predict the development of type 2 diabetes (37,38); meanwhile, elevated circulating ferritin was associated with incident nonalcoholic fatty liver disease (39) or accumulated hepatic fat content (40) . In the current study, controlling for GGT showed no material change in the association, suggesting that the observed ferritin-diabetes association was independent of the hepatic enzyme.
The potential mechanism linking elevated body iron stores with diabetes may largely rely on the catalytic effect of free iron, which could generate reactive oxygen species (7), thereafter inducing lipid peroxidation and tissue damage (41) . Indeed, excess iron deposition in pancreatic b cells could impair insulin synthesis and secretion (42, 43) . Moreover, iron accumulation in hepatocytes may cause impaired hepatic insulin extraction and metabolism (44, 45) . Furthermore, excess iron may enhance fatty acid oxidation and suppress glucose oxidation in muscle tissue (46) as well as influence insulin function and glucose uptake in adipose tissue (47) .
Although the observed moderate heterogeneity could not be explained by study design, ethnicity, follow-up duration, ferritin assay, and study quality in our meta-analysis, this heterogeneity was attenuated when we excluded the study of Jehn et al. (17) (I 2 = 19.5%; P = 0.26 for heterogeneity) or Jiang et al. (9) (I 2 = 37.0%; P = 0.11 for heterogeneity). In fact, removing both studies entirely eliminated heterogeneity (RR = 1.62 [95% CI: 1.35, 1.95]; I 2 = 0.0%; P = 0.49 for heterogeneity), suggesting potential sources of diversity among these studies. Thus, the heterogeneity might partially be explained by different degrees of potential confounding factors (adjustment for all metabolic syndrome components in the study of Jehn et al.) (17) and variations among the study populations (registered nurses in the study of Jiang et al.) (9) .
To our knowledge, this is the first prospective study in an Asian population to investigate the ferritin-diabetes association. Moreover, our meta-analysis including only prospective studies from both Western and Asian populations could provide a more solid estimate on the association. Admittedly, the current study had some limitations. First, the follow-up rate in our cohort study was only 77%, but it was still in an acceptable range comparable with other studies conducted in elderly people (48, 49) . Second, the current study was conducted in a middleaged and elderly population with a higher incidence of type 2 diabetes and the findings may not be generalizable to younger age groups. Nonetheless, the estimated RR in our study was similar to the pooled result in meta-analysis [RR = 1.60 (95% CI: 1.19, 2.14)], suggesting low probability of chance findings. Moreover, as in any epidemiological studies, the positive ferritindiabetes association does not prove causality and residual confounding is still possible. Lastly, the limited number of studies included in meta-analysis has restricted us from determining potential source of heterogeneity. In addition, the study-level data used in our meta-analysis might introduce ecological bias (50) , which cannot be verified unless individual patient data sets are available. The pooled RR might be overestimated due to unmeasured or residual confounding and should be interpreted with caution. Further studies are needed to understand the underlying mechanisms and to test whether lowering blood ferritin concentrations could prevent or reduce the risk of new-onset diabetes.
In summary, our study indicates that higher plasma ferritin concentrations could independently predict the risk of developing type 2 diabetes during a 6-y follow-up in an Asian population. The positive association was further confirmed by an updated meta-analysis pooling current data with 9 additional prospective studies. Our results provide solid evidence that elevated body iron stores are a risk factor for developing diabetes in both Western and Asian populations. Further research is needed to elucidate the potential biological mechanisms underlying this association.
